← Leaderboards
Ruitao Lin
University Of Tx Md Anderson Can Ctr
$859,215
Attributed
$1,534,491
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $370.6K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,534,491 · 2
By mechanism
R01$1,350,553 · 1
R21$183,938 · 1
Top collaborators
- Peter F Thall4 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Katy Rezvani$10,195,970
- Rafet Basar$1,227,277
- Juan Fueyo$8,546,462
- May Daher$980,227
- Faye Johnson$4,125,981
Others in their field
Other Emerging Leaders on “Individual Patient”
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Scott Topper · Broad Institute, Inc.$46,501,713
- Abraham Aizer Brody · New York University School Of Medicine$32,500,913
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Greg Yothers · University Of Chicago$25,122,895
- Hemali Phatnani · New York University School Of Medicine$23,091,371
Research focus
Individual PatientMonitorDoseHybridsMedicalModernizationComplexDesignFutilityGraphical User InterfaceMalignant NeoplasmsBayesian ModelingBiologicalBiological MarkersClinicClinical TrialsComputer SoftwareDecision MakingCharacteristicsEvaluationCationsFutureBayesian MethodPatient Safety
Grant awards (5)
Novel designs for multi-arm multi-dose multi-stage platform trials$183,938
R21 · FY2025 · LM · contact PI
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology$253,650
R01 · FY2024 · CA
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology$363,164
R01 · FY2023 · CA
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology$363,164
R01 · FY2022 · CA
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology$370,575
R01 · FY2021 · CA